Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela D Bhalla

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cancer Biology & Therapy|November 4, 2017
Co-targeting PI3K, mTOR, and IGF1R with small molecule inhibitors for treating undifferentiated pleomorphic sarcomaCaitlin D May, Sharon M Landers, Svetlana Bolshakov, et al.
JAMA Network Open|March 18, 2021
Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020Jace P Landry, Kelsey L Schertz, Yi-Ju Chiang, et al.
Science Advances|June 12, 2026
LPAR4 mediates resistance to interferon-induced stress in soft tissue sarcomaJin-Fen Xiao, Emily Y Ko, Ashley Smith, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 1, 2022
Experimental models of undifferentiated pleomorphic sarcoma and malignant peripheral nerve sheath tumorAngela D Bhalla, Sharon M Landers, Anand K Singh, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Spatially-Resolved Multiomic Atlas of Leiomyosarcoma Identifies Two Clinically Relevant Epigenetically-Driven Cell StatesRyan A Denu, Zhao Zheng, Yingda Jiang, et al.
Molecular Carcinogenesis|November 27, 2024
Plasma DNA Methylation-Based Biomarkers for MPNST Detection in Patients With Neurofibromatosis Type 1Katarzyna Tomczak, Manishkumar S Patel, Angela D Bhalla, et al.
Acta Neuropathologica|July 20, 2021
Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated stateVeena Kochat, Ayush T Raman, Sharon M Landers, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancer Biology & Therapy|November 4, 2017
Co-targeting PI3K, mTOR, and IGF1R with small molecule inhibitors for treating undifferentiated pleomorphic sarcomaCaitlin D May, Sharon M Landers, Svetlana Bolshakov, et al.
JAMA Network Open|March 18, 2021
Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020Jace P Landry, Kelsey L Schertz, Yi-Ju Chiang, et al.
Science Advances|June 12, 2026
LPAR4 mediates resistance to interferon-induced stress in soft tissue sarcomaJin-Fen Xiao, Emily Y Ko, Ashley Smith, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 1, 2022
Experimental models of undifferentiated pleomorphic sarcoma and malignant peripheral nerve sheath tumorAngela D Bhalla, Sharon M Landers, Anand K Singh, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Spatially-Resolved Multiomic Atlas of Leiomyosarcoma Identifies Two Clinically Relevant Epigenetically-Driven Cell StatesRyan A Denu, Zhao Zheng, Yingda Jiang, et al.
Molecular Carcinogenesis|November 27, 2024
Plasma DNA Methylation-Based Biomarkers for MPNST Detection in Patients With Neurofibromatosis Type 1Katarzyna Tomczak, Manishkumar S Patel, Angela D Bhalla, et al.
Acta Neuropathologica|July 20, 2021
Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated stateVeena Kochat, Ayush T Raman, Sharon M Landers, et al.
Pageof 2